SCHEMBL5378177

SCHEMBL5378177

CNc1c(Cl)ncn1CCO

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.37
ADORA2B P29275 1/20 0.37
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
YTHDC1 Q96MU7 2/20 0.34
MAPT P10636 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
DPP4 P27487 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
POLB P06746 1/20 0.31
ALDH1A1 P00352 1/20 0.31
PKM P14618 1/20 0.31
CTSL P07711 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5378181 0.75 YTHDC1 (0.40) LMNAADORA2BADORA2AADORA1YTHDC1
SCHEMBL17895776 0.75 NPSR1 (0.51) LMNAADORA2BADORA2AADORA1MAPT
SCHEMBL5371460 0.72
SCHEMBL5368001 0.72 ADORA2A (0.46) LMNAADORA2BADORA2AADORA1MAPT
SCHEMBL5378094 0.71 LMNA (0.37) LMNAADORA2BADORA2AADORA1MAPT
SCHEMBL5375069 0.68 CDK1 (0.43) MAPTALDH1A1
SCHEMBL5365928 0.67 MEN1 (0.38) LMNAADORA2BADORA2AADORA1MAPT
SCHEMBL5371084 0.66 MEN1 (0.40) LMNAADORA2BADORA2AADORA1MAPT
SCHEMBL15384497 0.65 LMNA (0.38) LMNAADORA2BADORA2AADORA1YTHDC1
SCHEMBL5378096 0.64 CYP1A2 (0.40) LMNAADORA2BADORA2AADORA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US claimed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US claimed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP claimed
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US disclosed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US disclosed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers KRT18, VIM, NDUFS6 LMNA 1593/4885ADORA2B 4448/4885ADORA2A 4607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.